The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disparities in next generation sequencing in a population-based community cohort of patients with advanced non-small cell lung cancer.
 
Carolyn Jean Presley
No Relationships to Disclose
 
Pamela R. Soulos
Research Funding - 21st Century Oncology (Inst)
 
Anne C. Chiang
Consulting or Advisory Role - Genentech; Genentech/Roche
Research Funding - Boehringer Ingelheim; Lilly; Millennium; OncoMed; Onyx
 
Janina A Longtine
No Relationships to Disclose
 
Kerin B. Adelson
Employment - Lyra health (I)
Honoraria - Genentech
Consulting or Advisory Role - Wellpoint
Travel, Accommodations, Expenses - Genentech
 
Roy S. Herbst
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lilly; Merck; Pfizer
Research Funding - Genentech; Merck
 
Nathan C Nussbaum
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Rachael Sorg
Employment - Flatiron Health
Research Funding - Flatiron Health
 
Amy Pickar Abernethy
Employment - Flatiron Health
Leadership - Athenahealth
Stock and Other Ownership Interests - AthenaHealth; Flatiron Health; Orange Leaf Associates
Consulting or Advisory Role - Bristol-Myers Squibb; Helsinn Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Pfizer (Inst)
 
Vineeta Agarwala
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Cary Philip Gross
Research Funding - 21st Century Oncology; Johnson & Johnson; Medtronic; Pfizer